GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.640
-0.065 (-3.81%)
Nov 16, 2026, 10:20 AM EST - Market open
GeoVax Labs Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.15 | 3.09 | 5.51 | 6.45 | 27.61 | 11.42 |
Cash & Short-Term Investments | 2.15 | 3.09 | 5.51 | 6.45 | 27.61 | 11.42 |
Cash Growth | -57.06% | -43.97% | -14.66% | -76.63% | 141.71% | 15.58% |
Receivables | - | - | 0.66 | - | - | 0.05 |
Prepaid Expenses | 0.96 | 2.23 | 1.77 | 1.43 | 1.33 | 0.16 |
Total Current Assets | 3.11 | 5.31 | 7.93 | 7.89 | 28.94 | 11.63 |
Property, Plant & Equipment | 0.25 | 0.94 | 0.15 | 0.21 | 0.23 | 0.16 |
Other Long-Term Assets | 0.06 | 0.09 | 0.07 | 1.19 | 2.17 | 0.01 |
Total Assets | 3.42 | 6.34 | 8.16 | 9.28 | 31.35 | 11.8 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.26 | 0.79 | 1.85 | 2.8 | 1.75 | 2.06 |
Accrued Expenses | 0.77 | 0.88 | 1.26 | 0.72 | 3 | 3.38 |
Current Portion of Leases | 0.11 | 0.26 | - | - | - | - |
Total Current Liabilities | 2.14 | 1.94 | 3.11 | 3.52 | 4.75 | 5.44 |
Long-Term Leases | 0.14 | 0.58 | - | - | - | - |
Other Long-Term Liabilities | - | - | - | - | - | 2 |
Total Liabilities | 2.28 | 2.52 | 3.11 | 3.52 | 4.75 | 7.44 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0.01 |
Additional Paid-In Capital | 165.81 | 154.64 | 134.4 | 110.13 | 105 | 68.73 |
Retained Earnings | -164.67 | -150.82 | -129.36 | -104.36 | -78.4 | -64.38 |
Total Common Equity | 1.15 | 3.83 | 5.05 | 5.76 | 26.6 | 4.36 |
Shareholders' Equity | 1.15 | 3.83 | 5.05 | 5.76 | 26.6 | 4.36 |
Total Liabilities & Equity | 3.42 | 6.34 | 8.16 | 9.28 | 31.35 | 11.8 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.25 | 0.84 | - | - | - | - |
Net Cash (Debt) | 1.9 | 2.24 | 5.51 | 6.45 | 27.61 | 11.42 |
Net Cash Growth | -62.06% | -59.28% | -14.66% | -76.63% | 141.71% | 17.95% |
Net Cash Per Share | 10.23 | 56.16 | - | - | - | - |
Filing Date Shares Outstanding | 0.54 | 0.12 | 0.02 | - | - | - |
Total Common Shares Outstanding | 0.42 | 0.07 | 0.02 | - | - | - |
Working Capital | 0.98 | 3.38 | 4.83 | 4.37 | 24.19 | 6.19 |
Book Value Per Share | 2.73 | 53.00 | 287.49 | - | - | - |
Tangible Book Value | 1.15 | 3.83 | 5.05 | 5.76 | 26.6 | 4.36 |
Tangible Book Value Per Share | 2.73 | 53.00 | 287.49 | - | - | - |
Machinery | - | 0.51 | 0.8 | 0.77 | 0.73 | 0.59 |
Leasehold Improvements | - | - | 0.12 | 0.12 | 0.12 | 0.12 |